Daniel Zakowiecki

Dr. Daniel Zakowiecki

CF Budenheim KG, Mainz, Rhineland-Palatinate, Germany
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2012 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
KGKatarzyna Anna Grzybowska
Katarzyna Anna Grzybowska
MPM. Paluch
M. Paluch
PWP. Wlodarczyk
P. Wlodarczyk
Andrzej GrzybowskiAndrzej Grzybowski
Andrzej Grzybowski
KKK. Kaminski
K. Kaminski
Irena Jankowska-SumaraIrena Jankowska-Sumara
Irena Jankowska-Sumara

25 June 2011 in Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
KAKarolina Adrjanowicz
Karolina Adrjanowicz
KKKamil Kaminski
Kamil Kaminski
KGKatarzyna Anna Grzybowska
Katarzyna Anna Grzybowska
Łukasz HawełekŁukasz Hawełek
Łukasz Hawełek
MPMarian Paluch
Marian Paluch
LGLukasz Guzik
Lukasz Guzik
Purpose To investigate the effect of cryogrinding on chemical stability of the diuretic agent furosemide and its mixtures with selected excipients. Methods Furosemide was ground at liquid nitrogen temperature for 30, 60, 120 and 180 min. Mixtures of furosemide-PVP and furosemide-inulin (1:1) were milled under cryogenic conditions. Materials were analyzed by XRD, UPLC, MS and NMR. Results Upon increasing the milling time, a significant build-up of an unidentified impurity 1, probably the main degradation product, was noticed. Cogrinding of furosemide with PVP and inulin worsened chemical stabilization of the pharmaceutical. The main degradation product formed upon cryomilling was subsequently identified as 4-chloro-5-sulfamoylanthranilic acid (CSA). Based on some theoretical considerations involving specific milling conditions, the milling intensity and an expected specific milling dose have been calculated. Results indicate that cryogenic grinding is capable to initiate mechanically induced decomposition of furosemide. Conclusions Cryogenic grinding can activate and accelerate not only structural changes (solid state amorphization) but also chemical decomposition of pharmaceuticals. A cryogenic milling device should be considered as a chemical reactor, where under favourable conditions chemical reactions could be mechanically initiated.



11 January 2011 in Philosophical Magazine
Verified
Journal Article
Closed access
KAK. Adrjanowicz
K. Adrjanowicz
KGKatarzyna Anna Grzybowska
Katarzyna Anna Grzybowska
KKK. Kaminski
K. Kaminski
Łukasz HawełekŁukasz Hawełek
Łukasz Hawełek
MPM. Paluch
M. Paluch
Daniel ZakowieckiDaniel Zakowiecki
Daniel Zakowiecki
To make full use of the advantages provided by amorphous pharmaceuticals it is necessary to understand the basic factors that determine their physical and chemical stability. Molecular mobility seems to be the most important one. Unfortunately, due to the exceedingly long time scale required for molecular motion in the glassy state, direct monitoring of the structural α-relaxation time ( ) in this temperature regime is rather difficult. A thorough investigation was carried out of the time scale of α-mobility in the glassy state of telmisartan (TEL). For this drug, global molecular mobility seems to be the most dominant factor responsible for its long-term stability. Based on some estimations obtained previously it was concluded that at room temperature, molecular mobility associated with the structural relaxation would exceed three years. To characterize the temperature behavior of structural relaxation below the glass transition temperature, T g, a modified Adam–Gibbs approach was used. Additionally, using results of dielectric measurements, a comparative analysis was performed of the molecular dynamics of amorphous TEL prepared by cryomilling as well as obtained by quench-cooling of the melt. An X-ray diffraction analysis was also carried out to confirm the long-term stability of amorphous TEL, whereas solubility studies revealed its markedly better solubility profile than that for the crystalline form. These findings have important implications for further handling of this drug.

22 July 2014 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
EKEwa Kaminska
Ewa Kaminska
KAK. Adrjanowicz
K. Adrjanowicz
MTM. Tarnacka
M. Tarnacka
KKK. Kolodziejczyk
K. Kolodziejczyk
Mateusz DulskiMateusz Dulski
Mateusz Dulski
KKK. Kaminski
K. Kaminski